BCL2L1 and cancer: IL‐6/STAT3 signalling upregulates the expression of genes involved with cell proliferation (c‐Myc and cyclin D1), angiogenesis (VEGF) and the inhibition of apoptosis (Bcl‐xL and survivin) in cancers.81